Corneal Confocal Microscopy: A Biomarker for Diabetic Peripheral Neuropathy

Area of Science:

• Ophthalmology
• Neurology
• Biomarker Development

Background:

• Diagnosing early diabetic peripheral neuropathy (DPN) is challenging due to limitations in current diagnostic endpoints.
• The cornea's dense innervation with small sensory fibers mirrors intraepidermal nerve fibers, making it a suitable target for DPN assessment.
• Corneal confocal microscopy (CCM) provides high-resolution, noninvasive imaging of corneal nerves.

Purpose of the Study:

• To review the framework for developing biomarkers for DPN.
• To evaluate the literature on CCM's use as a diagnostic biomarker in DPN research and clinical settings.
• To advocate for CCM's adoption as a surrogate endpoint in DPN clinical trials.

Main Methods:

• A narrative review synthesizing existing literature.
• Searches conducted on PubMed and Google Scholar using keywords: "corneal confocal microscopy," "diabetic neuropathy," "corneal sensitivity," and "clinical trials."
• Analysis of studies on CCM's diagnostic and prognostic value in DPN.

Main Results:

• Evidence indicates corneal nerve loss correlates with DPN incidence and severity.
• CCM can detect early signs of corneal nerve regeneration.
• These findings support CCM's utility as a surrogate endpoint for disease-modifying therapies.

Conclusions:

• Sufficient validation studies exist for CCM to meet FDA biomarker criteria.
• CCM can be incorporated as a primary endpoint in clinical trials for DPN therapies.
• This noninvasive technique enhances objective diagnosis and monitoring of DPN.